Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Median Technologies

< Previous 1 2 Next >
Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU
From Median Technologies
Via Business Wire
Median Technologies: Financial Communications Schedule for the First Half of 2025
From Median Technologies
Via Business Wire
Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024
From Median Technologies
Via Business Wire
Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data
From Median Technologies
Via Business Wire
Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening
From Median Technologies
Via Business Wire
Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results
From Median Technologies
Via Business Wire
Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024
From Median Technologies
Via Business Wire
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer
From Median Technologies
Via Business Wire
Median Technologies to host two webcasts on September 5, 2024
From Median Technologies
Via Business Wire
Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints
From Median Technologies
Via Business Wire
Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery
From Median Technologies
Via Business Wire
Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August
From Median Technologies
Via Business Wire
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024
From Median Technologies
Via Business Wire
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024
From Median Technologies
Via Business Wire
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
From Median Technologies
Via Business Wire
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
From Median Technologies
Via Business Wire
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
From Median Technologies
Via Business Wire
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
From Median Technologies
Via Business Wire
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
From Median Technologies
Via Business Wire
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
From Median Technologies
Via Business Wire
New Date for Median Technologies’ Webcasts: February 1st, 2024
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024
From Median Technologies
Via Business Wire
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
From Median Technologies
Via Business Wire
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
From Median Technologies
Via Business Wire
Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations
From Median Technologies
Via Business Wire
Median Technologies Selected for Support Under the French Government's ETIncelles Program
From Median Technologies
Via Business Wire
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
From Median Technologies
Via Business Wire
Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA
From Median Technologies
Via Business Wire
Median Technologies Reports 2023 Half-year Results and Business Indicators for the Third Quarter of 2023
From Median Technologies
Via Business Wire
First Results of Median Technologies’ iBiopsy® HCC Detection AI Model Developed on the PHELICAR Clinical Data Registry, to Be Presented at the ESMO Congress (Oct 20-24, 2023, Madrid, Spain)
From Median Technologies
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.